why choose us

First received: July 19, 2022

Clinical Trial: Oxytocin Pharmacokinetics and Pharmacodynamics

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Post Partum Hemorrhage

Study Type: INTERVENTIONAL


Official Title: Pharmacokinetics and Pharmacodynamics of Oxytocin in Cesarean Delivery

Brief Summary: Oxytocin is the first-line drug to promote contraction of the uterus and prevent atony immediately after delivery.Nonetheless, unpredictable uterine atony refractory to oxytocin affects roughly 250,000 parturients annually in the U.S. and rates are increasing.This two-part study will measure the action of oxytocin at cesarean delivery.The first part will measure the pharmacokinetics of a single intravenous (IV) dose of deuterium-labeled oxytocin.The second part will measure the pharmacodynamics of all plasma…

Read more